These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26894771)

  • 1. Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.
    Avogadri F; Gnjatic S; Tassello J; Frosina D; Hanson N; Laudenbach M; Ritter E; Merghoub T; Busam KJ; Jungbluth AA
    Am J Dermatopathol; 2016 Mar; 38(3):201-7. PubMed ID: 26894771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Situ Protein Expression Analysis of Melanocyte Differentiation Antigen TRP1 (Tyrosinase-Related Protein-1).
    Chen JM; Hernandez E; Frosina D; Ruh PA; Ariyan C; Busam KJ; Jungbluth AA
    Am J Dermatopathol; 2024 Sep; 46(9):563-571. PubMed ID: 39008470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers.
    Busam KJ; Kucukgöl D; Sato E; Frosina D; Teruya-Feldstein J; Jungbluth AA
    Am J Surg Pathol; 2005 Mar; 29(3):400-6. PubMed ID: 15725810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
    Clarkson KS; Sturdgess IC; Molyneux AJ
    J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of melanocyte-specific antibodies to human melanosomal proteins: expression patterns in normal human skin and in cutaneous pigmented lesions.
    Virador V; Matsunaga N; Matsunaga J; Valencia J; Oldham RJ; Kameyama K; Peck GL; Ferrans VJ; Vieira WD; Abdel-Malek ZA; Hearing VJ
    Pigment Cell Res; 2001 Aug; 14(4):289-97. PubMed ID: 11549113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
    Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
    Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
    Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
    Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
    Orchard GE
    Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
    Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
    Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
    Rochaix P; Lacroix-Triki M; Lamant L; Pichereaux C; Valmary S; Puente E; Al Saati T; Monsarrat B; Susini C; Buscail L; Delsol G; Voigt JJ
    Mod Pathol; 2003 May; 16(5):481-90. PubMed ID: 12748255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX-10 and TRP-1 expression in feline ocular and nonocular melanomas.
    Orlandi M; Porcellato I; Sforna M; Lo Giudice A; Giglia G; Mechelli L; Brachelente C
    Vet Pathol; 2024 Sep; 61(5):712-720. PubMed ID: 38613415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
    Lohmann CM; Iversen K; Jungbluth AA; Berwick M; Busam KJ
    Am J Surg Pathol; 2002 Oct; 26(10):1351-7. PubMed ID: 12360050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinase and nestin immunohistochemical expression in melanocytic nevi as a histopathologic pattern to trace melanocyte differentiation and nevogenesis.
    Murtas D; Pilloni L; Diana A; Casula L; Tomei S; Piras F; Ferreli C; Maxia C; Perra MT
    Histochem Cell Biol; 2019 Feb; 151(2):175-185. PubMed ID: 30232588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens.
    Lohmann CM; Hwu WJ; Iversen K; Jungbluth AA; Busam KJ
    Melanoma Res; 2003 Dec; 13(6):595-601. PubMed ID: 14646623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
    Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
    Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of dopachrome tautomerase detection in the assessment of melanocytic tumors.
    Filimon A; Zurac SA; Milac AL; Sima LE; Petrescu SM; Negroiu G
    Melanoma Res; 2014 Jun; 24(3):219-36. PubMed ID: 24709887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT; van Belle P; Elenitsas R; Elder DE
    Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
    de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
    Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.